316 related articles for article (PubMed ID: 27109957)
21. Liver transplantation for intrahepatic cholangiocarcinoma.
Lee DD; Croome KP; Musto KR; Melendez J; Tranesh G; Nakhleh R; Taner CB; Nguyen JH; Patel T; Harnois DM
Liver Transpl; 2018 May; 24(5):634-644. PubMed ID: 29514406
[TBL] [Abstract][Full Text] [Related]
22. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
[TBL] [Abstract][Full Text] [Related]
23. Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma.
Howell TC; Rhodin KE; Shaw B; Bao J; Kanu E; Masoud S; Bartholomew AJ; Gao Q; Anwar IJ; Ladowski JM; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Barbas AS; Lidsky ME
J Gastrointest Surg; 2024 May; 28(5):738-745. PubMed ID: 38704208
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma.
Ishii T; Ito T; Sumiyoshi S; Ogiso S; Fukumitsu K; Seo S; Taura K; Uemoto S
World J Surg Oncol; 2020 Dec; 18(1):319. PubMed ID: 33276780
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in the Setting of Cirrhosis.
De Martin E; Rayar M; Golse N; Dupeux M; Gelli M; Gnemmi V; Allard MA; Cherqui D; Sa Cunha A; Adam R; Coilly A; Antonini TM; Guettier C; Samuel D; Boudjema K; Boleslawski E; Vibert E
Liver Transpl; 2020 Jun; 26(6):785-798. PubMed ID: 32090444
[TBL] [Abstract][Full Text] [Related]
26. Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics.
Bergquist JR; Groeschl RT; Ivanics T; Shubert CR; Habermann EB; Kendrick ML; Farnell MB; Nagorney DM; Truty MJ; Smoot RL
HPB (Oxford); 2016 Nov; 18(11):886-892. PubMed ID: 27546172
[TBL] [Abstract][Full Text] [Related]
27. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification.
Yen CC; Yen CJ; Shan YS; Lin YJ; Liu IT; Huang HY; Yeh MM; Chan SH; Tsai HW
Histopathology; 2021 Oct; 79(4):556-572. PubMed ID: 33837585
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma.
Panjala C; Senecal DL; Bridges MD; Kim GP; Nakhleh RE; Nguyen JH; Harnois DM
Am J Transplant; 2010 May; 10(5):1263-7. PubMed ID: 20420633
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of combined hepatocellular-cholangiocarcinoma after hepatectomy or liver transplantation: A systematic review and meta-analysis.
Li DB; Si XY; Wang SJ; Zhou YM
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):12-18. PubMed ID: 30442549
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.
Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC
Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615
[TBL] [Abstract][Full Text] [Related]
32. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
[TBL] [Abstract][Full Text] [Related]
33. Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.
Zhang H; Yu X; Xu J; Li J; Zhou Y
Medicine (Baltimore); 2019 Sep; 98(38):e17102. PubMed ID: 31567946
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
[TBL] [Abstract][Full Text] [Related]
35. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
36. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L
J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811
[TBL] [Abstract][Full Text] [Related]
37. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.
Wang C; Chen C; Hu W; Tao L; Chen J
Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206
[TBL] [Abstract][Full Text] [Related]
38. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
39. Subcentimetric Incidental Intrahepatic Cholangiocarcinoma in an Explant Liver: Diagnostic Difficulty of a Rare Entity.
Mitra S; Geethanjali G; Rathi S; Behera A; Das A
Int J Surg Pathol; 2018 Dec; 26(8):739-744. PubMed ID: 29742944
[TBL] [Abstract][Full Text] [Related]
40. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
